BIO Comments on a Prospective Standard to Mitigate the Risk of Occupational Exposure to Infectious Agents in Healthcare and Healthcare-related Settings

Jul 29 2011
  BIO fully supports the creation of an infectious disease standard by the Occupational Safety and Health Administration (OSHA) to protect healthcare workers (HCWs), and BIO believes that vaccinations should be an integral part of this standard. The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) strongly recommends that HCWs receive vaccinations against the following diseases: hepatitis B, influenza, measles-mumps-rubella, varicella, and tetanus-diphtheria-pertussis. An OSHA standard that requires employers to make ACIP-recommended vaccines available to HCWs has the potential to impact worker safety significantly by increasing vaccination coverage.

Testimony in Support of USDA Research

Jul 28 2011
BIO submitted testimony in support of USDA research funding to the House Agriculture Subcommittee on Rural Development, Research, Biotechnology, and Foreign Agriculture. Ag research programs within the USDA have sparked agricultural innovation and will help to solve the critical food and energy security challenges facing a rapidly growing global population.

BIO Submits Comments on Financial Disclosure by Clinical Investigators Guidance

Jul 25 2011
BIO supports policies that emphasize disclosure of financial interests, rather than prohibiting certain relationships.

BIO Supports the Pandemic and All-Hazards Preparedness (PAHPA) Reauthorization Act of 2011

Jul 25 2011
In a letter to Representative Mike Rogers commending his support and introduction of H.R. 2405, BIO stresses the simultaneous reauthorization of Project BioShield and the Special Reserve Fund.

BIO Comments Following FDA Public Meeting: Ultra High Throughput Sequencing for Clinical Diagnostic Applications

Jul 23 2011
BIO commends the FDA for prospectively seeking input from industry to ensure that the regulatory environment is supportive of the rapid technological advancement of clinical diagnostic applications.

BIO’s Comments on the 340B Orphan Exemption

Jul 19 2011


Advanced Biofuels for Military Use

Jul 12 2011


BIO Submits Comments on FDA Draft Guidance for Safety Labeling Changes

Jul 12 2011


Testimony before House Energy and Commerce Subcommittee on Health

Jul 7 2011
Paul Hastings, testifying on behalf of BIO, discussed the importance of biotechnology in providing cures to diseases, and creating high-paying jobs.

BIO Comments on Proposed Rule Establishing an Influenza Vaccination Standard for Certain Medicare and Medicaid Providers and Suppliers

Jul 5 2011